Assessing the Impact of Two Methods of Continuous Veno-venous Hemodiafiltration on Time Nursing Work in Intensive Care
NCT ID: NCT00993733
Last Updated: 2016-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2010-09-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The CVVHDF is performed at the bedside, by a mobile generator with a semi permeable membrane, a blood circuit, a dialysate circuit and a feedback circuit.
The implementation of a CVVHDF requires the use of large amounts of biological liquid essential to enable the purification of blood during its passage through the artificial kidney.
The objective of this study is to assess time nursing work and the costs of each method.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient
NCT06369064
Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit
NCT01362088
The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function
NCT01077895
Simulation Training for Ultrasound Guided Central Venous Catheter Insertion
NCT00919308
Comparison of Femoral Versus Jugular Routes for Temporary Hemodialysis in Seriously Ill Patients
NCT00277888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The CVVHDF is performed at the bedside, by a mobile generator with a semi permeable membrane, a blood circuit, a dialysate circuit and a feedback circuit.
The implementation of a CVVHDF requires the use of large amounts of biological liquid essential to enable the purification of blood during its passage through the artificial kidney. The biological fluid may be supplied to the generator of CVVHDF in 2 ways:
* The conventional method, the most used: the generator operates with pockets containing dialysis fluid, these pockets to be changed regularly by nurses
* The on-line method: the generator operates with a specific water system supplying the dialysis fluid available in every room of the unit The objective of this study is to assess time nursing work and the costs of each method.
For this, 15 patients will be included in this study. Each patient performs 12 hours of each method (conventional and online), whose order will be randomized.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CVVHDF on-line
CVVHDF using a central water treatment plant, providing dialysate directly to the patient. They will perform a continuous veno-venous haemodiafiltration.
Continuous veno-venous haemodiafiltration
Dialysis procedure administrated to the patients with acute renal failure
classical CVVHDF
CVVHDF using a mobile generator with dialysate bags. They will perform a continuous veno-venous haemodiafiltration.
Continuous veno-venous haemodiafiltration
Dialysis procedure administrated to the patients with acute renal failure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous veno-venous haemodiafiltration
Dialysis procedure administrated to the patients with acute renal failure
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a renal failure requiring a CVVHDF for at least 2 cycles of 12 hours
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manolie Mehdi, MD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-A00695-34
Identifier Type: OTHER
Identifier Source: secondary_id
1008019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.